Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Candela Laser Approved for Treatment of Periorbital Wrinkles
Feb 2002
WAYLAND, Mass., Feb. 13 -- Candela Corp. has received FDA clearance from the US Food and Drug Administration to market the Vbeam pulsed dye laser for treatment of periorbital wrinkles.

"We're excited that this new clearance validates the anecdotal feedback we've been receiving virtually since the Vbeam's introduction two years ago -- namely, that this laser has exceptional utility in the treatment of periorbital wrinkles," said Gerard E. Puorro, Candela president and CEO.

"The FDA clearance can increase physicians' confidence in the Vbeam not only as an important laser for the medical treatment of vascular lesions, but as a laser for periorbital wrinkle reduction. We feel this new clearance confirms the Vbeam's versatility and utility as a staple in the physician's office," Puorro said.

lasersNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.